Table 5. Proportion of Ph-pos Cells by... | American Society of Hematology

Table 5.

Proportion of Ph-pos Cells by FISH/Cytogenetics Before ABMT and During Follow-up

Patients	Before ABMT	Day 30	Day 90	Day 180	Day 365	Day 730
1	94^4-150/100^4-151	92/88	94/100	90/90	84/100	BC
2	90/88	90/100	85/95	87/100	NE/100	95/100
3	NE/100	10/5	30/0	88/20	death
4	NE/88	23/0	10/0	13/9	90/79	92/75
5	90/100	80/100	80/85	95/90	96/100	BC
6	95/100	91/NM	75/87	91/100	90/100	92/100
7	92/100	90/100	88/100	92/100	94/100
8	95/100	92/100	86/100	95/100	90/100

Patients	Before ABMT	Day 30	Day 90	Day 180	Day 365	Day 730
1	94^4-150/100^4-151	92/88	94/100	90/90	84/100	BC
2	90/88	90/100	85/95	87/100	NE/100	95/100
3	NE/100	10/5	30/0	88/20	death
4	NE/88	23/0	10/0	13/9	90/79	92/75
5	90/100	80/100	80/85	95/90	96/100	BC
6	95/100	91/NM	75/87	91/100	90/100	92/100
7	92/100	90/100	88/100	92/100	94/100
8	95/100	92/100	86/100	95/100	90/100

Abbreviations: NE, not evaluable; NM, no analyzable metaphases; BC, blast crisis.

Proportion of rearranged cells on 500 interphase nuclei evaluated.

Proportion of Ph-pos cells on greater than 25 analyzable metaphases.